Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C9H14HgN2O5.C7H8N4O2.Na.HO |
| Molecular Weight | 650.97 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[OH-].[Na+].CN1C2=C(N=CN2)C(=O)N(C)C1=O.COC(C[Hg+])CNC(=O)NC(=O)CCC([O-])=O
InChI
InChIKey=BDFXZRBRZBBYDN-UHFFFAOYSA-L
InChI=1S/C9H15N2O5.C7H8N4O2.Hg.Na.H2O/c1-6(16-2)5-10-9(15)11-7(12)3-4-8(13)14;1-10-5-4(8-3-9-5)6(12)11(2)7(10)13;;;/h6H,1,3-5H2,2H3,(H,13,14)(H2,10,11,12,15);3H,1-2H3,(H,8,9);;;1H2/q;;2*+1;/p-2
| Molecular Formula | C7H8N4O2 |
| Molecular Weight | 180.164 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | HO |
| Molecular Weight | 17.0073 |
| Charge | -1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | Na |
| Molecular Weight | 22.98976928 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C9H14HgN2O5 |
| Molecular Weight | 430.81 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
Doses
| Dose | Population | Adverse events |
|---|---|---|
2 mL 1 times / 2 days multiple, intramuscular Dose: 2 mL, 1 times / 2 days Route: intramuscular Route: multiple Dose: 2 mL, 1 times / 2 days Sources: |
unhealthy |
Disc. AE: Encephalopathy... AEs leading to discontinuation/dose reduction: Encephalopathy (1 patient) Sources: |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Encephalopathy | 1 patient Disc. AE |
2 mL 1 times / 2 days multiple, intramuscular Dose: 2 mL, 1 times / 2 days Route: intramuscular Route: multiple Dose: 2 mL, 1 times / 2 days Sources: |
unhealthy |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Relative diuretic potential of intramuscular meralluride and oral hydrochlorothiazide in patients with edema. | 1970-03-01 |
|
| DIURETIC EFFECT OF POLYTHIAZIDE AND SODIUM MERALLURIDE. COMPARISON IN BEDFAST PATIENTS WITH EDEMA. | 1964-11-16 |
|
| Comparison of hydroflumethiazide and meralluride. New method for quantitative assay of diuretics in bedfast patients with edema. | 1961-07-29 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 09:46:39 GMT 2025
by
admin
on
Wed Apr 02 09:46:39 GMT 2025
|
| Record UNII |
3P7B4Q5T8A
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C166688
Created by
admin on Wed Apr 02 09:46:39 GMT 2025 , Edited by admin on Wed Apr 02 09:46:39 GMT 2025
|
PRIMARY | |||
|
8069-64-5
Created by
admin on Wed Apr 02 09:46:39 GMT 2025 , Edited by admin on Wed Apr 02 09:46:39 GMT 2025
|
PRIMARY | |||
|
DTXSID801028176
Created by
admin on Wed Apr 02 09:46:39 GMT 2025 , Edited by admin on Wed Apr 02 09:46:39 GMT 2025
|
PRIMARY | |||
|
m7203
Created by
admin on Wed Apr 02 09:46:39 GMT 2025 , Edited by admin on Wed Apr 02 09:46:39 GMT 2025
|
PRIMARY | Merck Index | ||
|
SUB03166MIG
Created by
admin on Wed Apr 02 09:46:39 GMT 2025 , Edited by admin on Wed Apr 02 09:46:39 GMT 2025
|
PRIMARY | |||
|
11764862
Created by
admin on Wed Apr 02 09:46:39 GMT 2025 , Edited by admin on Wed Apr 02 09:46:39 GMT 2025
|
PRIMARY | |||
|
19909
Created by
admin on Wed Apr 02 09:46:39 GMT 2025 , Edited by admin on Wed Apr 02 09:46:39 GMT 2025
|
PRIMARY | |||
|
129-99-7
Created by
admin on Wed Apr 02 09:46:39 GMT 2025 , Edited by admin on Wed Apr 02 09:46:39 GMT 2025
|
ALTERNATIVE | |||
|
3P7B4Q5T8A
Created by
admin on Wed Apr 02 09:46:39 GMT 2025 , Edited by admin on Wed Apr 02 09:46:39 GMT 2025
|
PRIMARY | |||
|
SUB14517MIG
Created by
admin on Wed Apr 02 09:46:39 GMT 2025 , Edited by admin on Wed Apr 02 09:46:39 GMT 2025
|
PRIMARY | |||
|
1885
Created by
admin on Wed Apr 02 09:46:39 GMT 2025 , Edited by admin on Wed Apr 02 09:46:39 GMT 2025
|
PRIMARY | |||
|
100000076543
Created by
admin on Wed Apr 02 09:46:39 GMT 2025 , Edited by admin on Wed Apr 02 09:46:39 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |